A comparative study of the prevalence of the metabolic syndrome and its components in type 2 diabetic patients in two Caribbean islands using the new International Diabetes Federation definition

Archives of Physiology and Biochemistry

Volumn 113, Issue 4-5, 2007, Pages 202-210

  Ezenwaka, C E ^a   Nwagbara, E ^b   Seales, D ^a   Okali, F ^b   Hussaini, S ^b   Raja, B ^b   Wheeler, V ^b   Sell, H ^c   Avci, H ^c   Eckel, J ^c  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b Tobago Regional Health Authority   (Trinidad and Tobago)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Cardiovascular disease; Caribbean; Central obesity; Diabetes mellitus; Metabolic syndrome; Prevalence

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE; COMPARATIVE STUDY; DEMOGRAPHY; ETHNOLOGY; FEMALE; GEOGRAPHY; HUMAN; INTERNATIONAL COOPERATION; LIFESTYLE; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; RISK FACTOR; SEXUAL DEVELOPMENT; TRINIDAD AND TOBAGO;

AGE DISTRIBUTION; BLOOD PRESSURE; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; GEOGRAPHY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERNATIONAL AGENCIES; LIFE STYLE; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SEX CHARACTERISTICS; TRINIDAD AND TOBAGO;

EID: 37549008338     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450701475201     Document Type: Article

References (54)

1. Adult Treatment Panel III. 2001. Expert Panel on the detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 285:2486-97.
2. Alberti KG, Zimmet P, Shaw J. 2006. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. DiabetMed 23(5):469-80.
3. Anderson JW, Akanji AO. 1991. Dietary fiber-an overview. Diabetes Care 14:1126-31.
4. Beckles GL, Miller GL, Kirkwood BR, Alexis SD, Carson DC, Byam NT. 1986. High total and cardiovascular disease mortality in adults of Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet 1(8493):1298-301.
5. Berg AH, Du Combs TPX, Brownlee M, Scherer PE. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 7:947-53.
6. Brackenridge BP. 1999. Diabetes education: a global perspective. Diabetes Spectrum 12:132.
7. Campos H, Mata L, Siles X, Vives M, Ordovas JM, Schaefer EJ. 1992. Prevalence of cardiovascular risk factors in rural and urban Costa Rica. Circulation 85:648-58.
8. Central Statistical Office. 1998. Republic of Trinidad and Tobago. Office of the Prime Minister. Population and housing census. Vol. II. Age structure, religion, ethnic group, education. Port of Spain: Central Statistical Office.
9. Central Statistical Office. 1999. The Government of the Republic of Trinidad and Tobago. Ministry of Planning and Development, Central Statistical Office. Population, social and vital statistics, five leading causes of death. Online at: http://www.cso.gov.tt/ (accessed 15 January 2007).
10. Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M. 2006. Global and regional mortality from ischaemic heart disease and stroke attributable to higher than optimal blood glucose concentration: comparative risk assessment. Lancet 368:1651-9.
11. Despres JP, Lemieux I, Prud'homme D. 2001. Treatment of obesity: need to focus on high-risk abdominally obese patients. BMJ 322:717-20.
12. Ezenwaka CE, Davis G. 2000. Increased cardiovascular risk factors in newly diagnosed type 2 diabetic patients in a primary health care center in Trinidad. Diabetes Res Clin Pract 50(2):137-45.
13. Ezenwaka CE, Kalloo R. 2005. Caribbean female patients with type 2 diabetes mellitus have lower serum levels of adiponectin than non-diabetic subjects. Neth J Med 63(2):64-9.
14. Ezenwaka CE, Offiah NV. 2003. Patients' health education and diabetes control in a developing country. Arta Diabetologica 40:173-5.
15. Ezenwaka CE, Offiah NV. 2002. Abdominal obesity in Type 2 diabetic patients visiting primary healthcare clinics in Trinidad, West Indies. Scand J Primary Health Care 20(3):177-82.
16. Ezenwaka CE, Offiah NV. 2001a. Cardiovascular risk of obese and non-obese patients with type 2 diabetes in the West Indies. J Biomed Sci 8(4):314-20.
17. Ezenwaka CE, Offiah NV. 2001b. Differences in glycemic control and cardiovascular risk in primary care patients with type 2 diabetes in West Indies. Clin Exp Med 1(2):91-8.
18. Ezenwaka CE, Kalloo R. 2004a. Glycaemic responses after ingestion of 3 local carbohydrate-based foods in West Indian patients with type-2 diabetes mellitus. Clinical Nutrition 23(4):631-40.
19. Ezenwaka CE, Kalloo R. 2004b. Postprandial glucose control in Type 2 diabetic patients visiting two different primary care clinics in Trinidad, West Indies. West Indian Med J 53(6):392-9.
20. Ezenwaka CE. 2003. Metabolic control of type 2 diabetic patients commonly treated with sulphonylureas in a developing country. East Afr Med J 80(4):175-80.
21. Ezenwaka CE, Akanji AO, Akanji BO, Unwin NC, Adejuwon CA. 1997. The prevalence of insulin resistance and other cardiovascular disease risk factors in healthy elderly southwestern Nigerians. Atherosclerosis 128:201-11.
22. Friedewald WT, Levy RI. 1972. Fredrickson DS Estimation of the concentration of low-density lipoprotein in plasma without use of preparative ultracentrifuge. Clin Chem 18:499-502.
23. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. 1980. Coronary heart disease risk and impaired glucose tolerance-the Whitehall study. Lancet 1:1373-6.
24. International Diabetes Federation. 2006. IDF World-wide definition of the metabolic syndrome. Online at: www.idf.org/ metabolic_syndrome (accessed 19 December 2006).
25. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-9.
26. Kahn R, Buse J, Ferrannini E, Stern M. 2005. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the study of Diabetes. Diabetes Care 28(9):2289-304.
27. Keys A, Aravanis C, Blackbum H, Van Buchem FS, Buzina R, Djordjevic BS, Fidanza F, Karvonen MJ, Menotti A, Puddu V, et al. 1972. Coronary heart disease: overweight and obesity as risk factors. Ann Intern Med 77:15-27.
28. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. 2002. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-16.
29. Kim C, Park J, Park J, Kang E, Ahn C, Cha B, Lim S, Kim K, Lee H. 2006. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity. Obesity (Silver Spring). 14(7):1164-71.
30. Lempiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J. 1999. Insulin resistance syndrome predicts coronary heart disease events in elderly non-diabetic men. Circulation 100:123-8.
31. Lippel K, Tyroler H, Eder H, Gotto A, Vahouny G. 1981. Relationship of hypertriglyceridaemia to atherosclerosis. Atherosclerosis 1:406-17.
32. Lopez-Bermejo A, Botas P, Funahashi T, Delgado E, Kihara S, Ricart W, Fernandez-Real JM. 2004. Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clin Endo 60:256-63.
33. Maggi S, Noale M, Gallina P, Bianchi D, Marzari C, Limongi F, Crepaldi G. ILSA Working Group. 2006. Metabolic syndrome, diabetes and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on aging. J Gerontol A Biol Sci Med Sci 61(5):505-10.
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-19.
35. Miller GJ, Beckles GL, Maude GH, Carson DC, Alexis SD, Price SG, Byam NT. 1989. Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James Survey, Trinidad. Int J Epidemiol 18:808-17.
36. Miller GJ, Cooper JA, Beckles GL. 2005. Cardiorespiratory fitness, all-cause mortality and risk of cardiovascular disease in Trinidadian men-the St James Survey. Int J Epidemiol 34(6):1387-95.
37. Miller GJ, Maude GH, Beckles GLA. 1996. Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad. J Epidemiol Comm Health 50:497-504.
38. Miller GL, Kirkwood BR, Beckles GL, Alexis SD, Carson DC, Byam NT. 1988. Adult male all-cause, cardiovascular and cerebrovascular mortality in relation to ethnic group, systolic blood pressure and blood glucose concentration in Trinidad, West Indies. Int J Epidemiol 17(1):62-9.
39. Onat A, Ceyhan K, Basar O, Erer B, Tobrak S, Sansoy V. 2002. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 165:285-92.
40. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ. 1994. Waist circumference and abdominal saggittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73:460-8.
41. Reaven GM. 1988. Role of insulin resistance in human disease. Diabetes 37:1595-607.
42. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. 1995. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ 310(6979):555-9.
43. Rosengren A, Welin L, Tsipigianni A, Wilhelmsen L. 1989. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle-aged diabetic men: a general population study. Br Med J 299:1127-31.
44. Scuteri A, Najja S, Morrell C, Lakatta E. 2005. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events. Diabetes Care 28:882-7.
45. Snehalatha C, Ramachandran A, Vijay V, Viswanathan M. 1994. Differences in plasma insulin responses in urban and rural Indian: a study in Southern Indian. Diabet Med 11:445-8.
46. Stamler J, Vaccaro O, Neaton JD, Wentworth D. 1993. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-44.
47. Stratton IM, Alder AI, Neil HAW, Mathews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. 2000. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-12.
48. The Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Eng J Med 329: 977-86.
49. UKPDS. 1998. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837-53.
50. Valsamakis G, Chetty R, McTernan PG, Al-Daghri NM, Barnett AH, Kumar S. 2003. Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab 25(2):131-5.
51. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-5.
52. World Health Organisation. 1999. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. World Health Organisation, Geneva.
53. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY. 2006. Epidemic obesity and type 2 diabetes in Asia. Lancet 268:1681-8.
54. Zietz B, Herfarth H, Paul G, Ehling A, Muller-Ladner U, Scholmerich J, Schaffler A. 2003. Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett 545(2/3): 103-4.